Stem Cell Banking Market Overview:
Stem cell banking market involves the collection and preservation of various types of stem cells such as cord and adult stem cells for future applications. After collection, these stem cells need to undergo a large number processing and analysis procedure, the viability and different genetic tests are conducted on the stem cells. These stem cells are cryopreserved and stored for decades. The global stem cell banking market was valued at $1,986 million in 2016, and is estimated to reach $6,956 million by 2023, registering a CAGR of 19.5% from 2017 to 2023.
Full report:-https://www.futureindustryinsight.com/product/stem-cell-banking-market-research-report-2017-2023/
The major driving factors of the market growth are increase in R&D activities in regards with applications of stem cells and increase in prevalence of fatal chronic diseases. The large number of births occurring globally and growth in GDP & disposable income are expected to further boost the market growth. Moreover, initiative taken by organizations and companies to spread awareness in regards with the benefits of stem cells and untapped market in the developing regions are anticipated to fuel the market growth. However, high processing & storage cost and lack of acceptance and awareness in developing regions adversely affect the market growth.
Cell type segment review
Based on the cell type, the market is segmented into umbilical cord stem cells, adult stem cells, and embryonic stem cells. Umbilical cord stem cells segment dominates the market, as these stem cells can be used to treat almost 80 diseases and the extraction process is easy and does to harm the newborn in any way. 
Bank type segment review
Depending on bank type, the market is bifurcated into private and public stem cell banks. Private stem cell bank is the dominant segment. Although the number of public banks present are more than private banks, the revenue generated by private stem cell banks is more, which contributes toward the growth of the stem cell banking market.
Key geographical segment
As per region, the stem cell banking market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the largest market share in the stem cell banking market in 2016, and is expected to retain its dominance throughout the forecast period.
The key players operating in the global stem cell banking market include Cord Blood Registry, ViaCord, Cryo-Cell, China Cord Blood Corporation, Cryo-Save, New York Cord Blood Program, CordVida, Americord, CryoHoldco, and Vita34.
Other prominent players in the value chain include Caladrius Biosciences, Cryoviva, Smart Cells International Ltd., Stemade Biotech, Cytori Therapeutics, Cellular Dynamics International, PerkinElmer, and Reelabs.
Key Benefits
- This report entails a detailed quantitative analysis of the current market trends from 2016 to 2023 to identify the prevailing opportunities.
- Market estimations are based on comprehensive analysis of the key developments in the industry.
- The global market is comprehensively analyzed with respect to cell type, bank type, service type, utilization, and region.
- In-depth analysis based on region assists to understand the regional market to assist in strategic business planning.
- The development strategies adopted by key manufacturers are enlisted to understand the competitive scenario of the market.
Stem Cell Banking Market Key Segments:
By Cell Type
- Umbilical Cord Stem Cell
- Cord Blood
- Cord Tissue
- Placenta
- Adult Stem Cell
- Embryonic Stem Cell
By Bank Type
- Public
- Private
By Service Type
- Collection & Transportation
- Processing
- Analysis
- Storage
By Utilization
- Used
- Unused
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Singapore
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA